Teresa Brophy Bair, Chief Legal Officer at Kura Oncology, Inc. (KURA), sold 17,610 shares at $8.94 ($157K) on 2025-09-29, disclosed to the SEC on 2025-09-29.
Scheduled sale ($157k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.94 | 8,805 | $79K | 50.0% |
| 2 | $8.94 | 8,805 | $79K | 50.0% |
| Total | $8.94 avg | 17,610 | $157K | 100% |
| Filing → |
| KURA | SELL | 2026-05-20 | $21K | — | Filing → |
| KURA | SELL | 2026-01-27 | $95K | — | Filing → |
| KURA | SELL | 2025-11-14 | $197K | — | Filing → |